Military Report Slams DMAA While GNC Claims Victory
This article was originally published in The Tan Sheet
A Department of Defense safety review panel does not find a conclusive causal association between DMAA and adverse events, including four service members’ deaths, a conclusion that “delighted” retailer GNC. But DoD’s ban on sales of DMAA products in military exchanges and concessions remains in place.
You may also be interested in...
FDA seeks DMAA product seizure; skin tag remover study flawed – ERSP; Plan B One-Step approved fully OTC; FDA continues evaluating laxative TEA; FDA hosts supply chain public hearing; energy drink marketing to youths challenged; more news In Brief.
FDA issues a consumer warning about the potentially lethal effects of DMAA, and promises to use “all available tools at its disposal to ensure the dietary supplements containing” the stimulant “are no longer distributed and available for sale.”
The Medicines and Healthcare products Regulatory Agency bans use of dimethylamylamine in the United Kingdom. Meanwhile, FDA has stopped short of an all-out ban, though retailers and insurance carriers largely have turned their backs on DMAA.